by palligoelme@gmail.com | Jan 5, 2026 | Clinical Trials
Conditions: D012139; D003924 Interventions: Other: Discontinuation of renal replacement therapy Sponsors: Assistance Publique – Hôpitaux de Paris Completed Conditions: D012139; D003924 Interventions: Other: Discontinuation of renal replacement therapy...
by palligoelme@gmail.com | Jan 5, 2026 | Clinical Trials
Conditions: Parkinson’s Disease (PD); Freezing of Gait; Freezing of Gait Symptoms in Parkinson Disease Interventions: Drug: Atomoxetine; Drug: Placebo Sponsors: Radboud University Medical Center; University of Waterloo; Macquarie University, Australia Not yet...
by palligoelme@gmail.com | Jan 5, 2026 | Clinical Trials
Conditions: Exercise Training; Exercise Behavior; Exercise Adherence Challenges; Motivation for Physical Activity; Motivational Enhancement Interventions: Behavioral: Group 1: Self-efficacy-based AI coaching; Behavioral: Group 2: Static AI Affirmations Sponsors:...
by palligoelme@gmail.com | Jan 5, 2026 | Clinical Trials
Conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation; Blood Flow Restriction (BFR) Training Effects Interventions: Other: Blood flow restriction training; Other: Standard ACL rehabilitation Sponsors: Hospital MAZ Not yet recruiting Conditions:...
by palligoelme@gmail.com | Jan 2, 2026 | Clinical Trials
Conditions: Stage III Breast Cancer Interventions: Diagnostic Test: Fluoroestradiol (18F) Sponsors: Asan Medical Center Recruiting Conditions: Stage III Breast Cancer Interventions: Diagnostic Test: Fluoroestradiol (18F) Sponsors: Asan Medical Center...
by palligoelme@gmail.com | Jan 2, 2026 | Clinical Trials
Conditions: Circadian Rhythm; Postoperative Sleep Disturbance Interventions: Drug: Esketamine; Drug: Normal Saline Sponsors: Zhuan Zhang Not yet recruiting Conditions: Circadian Rhythm; Postoperative Sleep Disturbance Interventions: Drug: Esketamine; Drug: Normal...